NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-004-2022-0-CA-01 STAR POLYMER DRUG CONJUGATES CA National Stage 3195623 Pending
NIBIB E-117-2023-0-US-01 FLUORINATED COUPLING PARTNER COMPOUNDS FOR RADIOLABELING BIOMOLECULES AND METHODS OF MAKING AND USING THE SAME US 63/459,079 Expired
NIAID E-178-2019-1-US-01 STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS US National Stage 18/031,602 Pending
NIDCR E-107-2022-1-KR-01 TRIPHENYL CALCILYTIC COMPOUNDS FOR THE TREATMENT OF AUTOSOMAL DOMINANT HYPOCALCEMIA TYPE 1 (ADH1) KR National Stage 10-2023-7012476 Pending
NIEHS E-241-2020-0-US-02 Massively Paralleled Multi-patient Assay For Pathogenic Infection Diagnosis And Host Physiology Surveillance Using Nucleic Acid Sequencing US National Stage 18/031,165 Pending
NIAID E-042-2018-0-JP-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE JP DIV 2023-063846 Pending
NCATS E-120-2023-0-US-01 Small molecule modulators for the voltage-gated sodium channel 1.7 (NaV1.7) and their therapeutic applications US 63/495,159 Expired
NIMH E-070-2023-0-US-01 SYSTEMS AND METHODS FOR MULTICHANNEL INDIVIDUALIZED STIMULATION THERAPY US 63/495,244 Expired
NHLBI E-052-2022-0-PC-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES PCT PCT PCT/US2023/017895 Expired
NHLBI E-036-2022-0-PC-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS PCT PCT PCT/US2023/017885 Expired
NCATS E-026-2016-0-US-02 Compounds for Improving mRNA Splicing US CON 18/297,569 Pending
NLM E-111-2022-1-US-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM US 63/458,054 Expired
NIAID E-052-2017-4-JP-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection JP DIV 2023-061823 Abandoned
NIAID E-060-2022-0-PCT-02 BETA GLOBIN MIMETIC PEPTIDES AND THEIR USE PCT PCT PCT/US2023/065432 Expired
NCI E-175-2016-0-IL-01 ANTI-KRAS-G12D T CELL RECEPTORS IL DIV 301894 Issued
NCI E-173-2020-0-KR-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 KR National Stage 10-2023-7011380 Pending
NINDS E-061-2023-0-US-01 SYSTEMS AND METHODS FOR PATTERNED MULTI-SLICE EXCITATION IN MAGNETIC RESONANCE IMAGING US 63/493,962 Expired
NIAID E-131-2020-7-US-01 Anti-Coronavirus Antibodies And Methods Of Use US CON 18/194,105 12172038 Issued PDF
NCI E-189-2020-1-JP-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION JP National Stage 2023-520143 Pending
NCI E-103-2023-0-US-01 Peptide-pulsed MHC class II semi-allogeneic dendritic cell vaccine induces more efficacious anti-tumor responses US 63/456,176 Expired
NCATS E-253-2017-0-US-02 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME US DIV 18/128,603 12435047 Issued PDF
NCI E-167-2021-0-PC-01 Methods and Compositions for the Treatment for Inflammation and Fibrosis in Retinal
Neovascular Diseases 		PCT PCT PCT/US2023/065141 Expired
NLM E-023-2023-0-PC-01 MODIFICATION-DEPENDENT ENRICHMENT OF DNA BY GENOME OF ORIGIN PCT PCT PCT/US2023/016926 Expired
NICHD E-010-2021-0-EP-01 ENHANCED ANTIGEN REACTIVITY OF IMMUNE CELLS EXPRESSING A MUTANT NON-SIGNALING CD3 ZETA CHAIN EP National Stage 21824143.8 Pending
NCI E-136-2023-0-US-01 ALLOSTERIC INHIBITORS OF THE POLO-LIKE KINASE 1 POLO BOX DOMAIN, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER US 63/455,608 Expired
NCI E-173-2020-0-AU-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 AU National Stage 2021336399 Pending
NIDDK E-067-2022-1-PCT-02 A3 ADENOSINE RECEPTOR POSITIVE ALLOSTERIC MODULATORS PCT PCT PCT/US2023/016769 Expired
NCI E-163-2020-0-EP-01 LZK-TARGETING DEGRADERS AND METHODS OF USE EP National Stage 21790644.5 Pending
NCI E-189-2020-1-CA-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION CA National Stage 3194229 Pending
NCI E-167-2019-0-DE-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY DE EP 21787116.9 Issued
NCI E-167-2019-0-FR-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY FR EP 21787116.9 Issued
NCI E-167-2019-0-IT-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY IT EP 21787116.9 Issued
NCI E-167-2019-0-ES-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY ES EP 21787116.9 Issued
NCI E-167-2019-0-EP-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY EP National Stage 21787116.9 Issued
NCI E-167-2019-0-GB-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY GB EP 21787116.9 Issued
NIAID E-073-2022-0-PC-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT PCT/US2023/065068 Expired
NCI E-189-2020-1-EP-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION EP National Stage 21810460.2 Pending
NCI E-173-2020-0-EP-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 EP National Stage 21778318.2 Pending
NCI E-173-2020-0-IN-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 IN National Stage 202347022460 Pending
NIAID E-080-2022-0-PC-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT PCT/US2023/064996 Expired
NIAID E-079-2022-0-PC-01 BASE-COVERED HIV-1 ENVELOPE ECTODOMAINS AND THEIR USE PCT PCT PCT/US2023/065009 Expired
NCATS E-042-2022-0-PC-01 SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS PCT PCT PCT/US2023/016357 Expired
NCI E-159-2019-0-HK-07 HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) HK EP 62023070659.5 Pending
NIAID E-080-2022-0-ZA-01 BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE ZA National Stage 2024/07299 Pending
NCI E-054-2023-0-US-01 T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53 US 63/492,256 Expired
NCI E-122-2023-0-US-02 V2 PEPTIDE VACCINE FOR HIV-1 US 63/492,258 Expired
NHLBI E-080-2023-0-US-01 ENZYMATIC RADIOSYNTHESIS OF DEOXY-[18F] FLUOROCELLOBIOSE AND DEOXY-[18F]
FLUOROCELLOTRIOSE 		US 63/492,302 Expired
NEI E-028-2023-0-PC-01 PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND USE FOR TREATING RETINAL
DEGENERATION 		PCT PCT PCT/US2023/064947 Expired
NCI E-211-2020-0-US-02 PLK1 POLO BOX DOMAIN INHIBITORS AND METHOD OF TREATING CANCER US National Stage 18/028,463 Pending
NICHD E-009-2021-0-US-02 THERAPEUTICS AGAINST PATHOGENIC CORONAVIRUSES US National Stage 18/028,490 Pending